Explore
Validate
LearnGMA-360
antibody from Green Mountain Antibodies
Targeting: ADAMTS13
C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GMA-360 - Provider product page
- Provider
- Green Mountain Antibodies
- Product name
- Anti-ADAMTS13
- Antibody type
- Monoclonal
- Antigen
- ADAMTS13
- Description
- GMA-360 binds the disintegrin domain of ADAMTS13 (A Disintegrin and Metalloprotease with TromboSpondin type 1 repeats, member 13). It is useful for affinity purification, immunostaining in cells, Western blot, and ELISA.
- Reactivity
- Human
- Host
- Mouse
- Antibody clone number
- GMA-360
- Vial size
- 0.1mg, 0.5mg
Submitted references Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.
Jian C, Xiao J, Gong L, Skipwith CG, Jin SY, Kwaan HC, Zheng XL
Blood 2012 Apr 19;119(16):3836-43
Blood 2012 Apr 19;119(16):3836-43
Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.
Li D, Xiao J, Paessler M, Zheng XL
Thrombosis and haemostasis 2011 Nov;106(5):947-58
Thrombosis and haemostasis 2011 Nov;106(5):947-58
No comments: Submit comment
No validations: Submit validation data